Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that subsidiary HempMeds® Mexico will be a Platinum Sponsor at the Cannapeutas Clinical Perspective Cannabinoid Symposium on Dec. 7 at the National Autonomous University of Mexico in Mexico City.
|
SAN DIEGO, /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that subsidiary HempMeds® Mexico will be a Platinum Sponsor at the Cannapeutas Clinical Perspective Cannabinoid Symposium on Dec. 7 at the National Autonomous University of Mexico in Mexico City. Also, Elizalde, who has contributed greatly to Mexico's inclusion of cannabis into society and science, will be featured as a special guest speaker at this symposium discussing "A New Age of Standardized Applications for Cannabinoids" on December 7 at 7:30 a.m. The symposium, entitled "El Simposio Cannabanoides: Una Perspectiva Clinica," will be a private, exclusive event under the direction of key players in the medical and pharmaceutical fields in Mexico, as well as those involved in the implementation, investigation and education of the use of cannabis in the country. This event will provide an invaluable opportunity for these industry leaders to network regarding the future of the legality of cannabis in Mexico. "We are excited to sponsor this year's Cannapeutas Clinical Perspective Cannabinoid Symposium," said Raul Elizalde, President of HempMeds® Latin America. "The information garnered at this event will ultimately aid in formulating sound policy, medical innovation and infrastructure as Mexico transitions to a federal medical cannabis program." Since the establishment of HempMeds® Mexico, the company has worked to promote access to cannabidiol (CBD) products by supporting non-profit organizations that help provide quick access and by working with the government to establish an importation process that allows patients to get Real Scientific Hemp Oil-X™ (RSHO-X™) with ease. HempMeds® Mexico was also the first company to receive a COFEPRIS federal government import permit for a cannabis product, RSHO-X™, for a medical indication. Recently, the company was also the first to receive several other import permits for its cannabis products under new federal regulations released last month. "Our company was the first to have a federally legal CBD product in Mexico and we look forward to sponsoring an event that is slated to make history as well," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "Hopefully, we can end the stigma about cannabis through education initiatives while educating people around the world about the plethora of benefits that cannabinoids have to offer." About HempMeds® Mexico HempMeds® Mexico is a Mexico-based company that made history by being the first company to receive a COFEPRIS federal government import permit for the cannabis product RSHO-X™ for a medical indication. HempMeds® Mexico plans to work directly with the Mexican government to safely and legally provide access to CBD hemp oil products. For more information, please review the company's website at http://www.hempmeds.mx. About Medical Marijuana, Inc. To see Medical Marijuana, Inc.'s corporate video, click here. Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop. FORWARD-LOOKING DISCLAIMER FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE LEGAL DISCLOSURE CONTACT: Andrew Hard, Chief Executive Officer
SOURCE Medical Marijuana, Inc. |
||
Company Codes: OTC-PINK:MJNA, OTC-QB:MJNA |
View original content:
